Breast Cancer

Clinical highlights, expert perspectives, and pivotal data from the ASCO breast cancer sessions, showcasing emerging evidence and advancing therapeutic strategies.

Breast Cancer

Group of three medical professionals, including Dr. Hope Rugo, discussing breast cancer updates from ASCO 2026.

Breast Cancer

07/13/2026

7 Key Breast Cancer Updates From ASCO 2026

Hope Rugo, MD, FASCORahul Gosain, MD, MBARohit Gosain, MD

Insights from ASCO 2026 on antibody-drug conjugates reshaping metastatic triple-negative breast cancer treatment.

Breast Cancer

06/14/2026

Insights from ASCO 2026: Antibody–Drug Conjugates Continue to Reshape Metastatic Triple-Negative Breast Cancer

Stephanie Haddad, DO

Healthcare professionals Alexis LeVee, MD, and Hope Rugo, MD, FASCO, discuss community perspectives on ADCs and novel agents in triple-negative breast cancer (TNBC).

Breast Cancer

06/12/2026

Breast Oncologists Discuss the Current Paradigm and Future Advancements for ADCs in TNBC

Alexis Levee, MDHope Rugo, MD, FASCO

Molecular profiling and treatment sequencing in HR-positive breast cancer with Dr. Ya Haddy Sallah and Dr. Jimmitti Teysir.

Breast Cancer

06/12/2026

How Molecular Profiling Guides Targeted Therapy Options in HR–Positive Breast Cancer

Jimmitti Teysir, MDYa Haddy Sallah, MD, MPH

Overview of GLP-1 receptor agonists and their role in breast cancer treatment, featuring insights from Cleveland Clinic expert Jasmin Hundal, MD, MS, MPH.

Breast Cancer

06/11/2026

GLP-1 Receptor Agonists in Breast Cancer: Moving Beyond Weight Loss Toward Cancer Prevention and Survivorship

Jasmin Hundal, MD

Experts discuss innovative treatment strategies for metastatic ER-positive breast cancer against a city skyline at sunset. Focus on oncology, breast cancer, and advanced therapies.

Breast Cancer

06/11/2026

How To Approach Endocrine Therapies for Metastatic Breast Cancer in the Adjuvant CDK4/6 Inhibitor Era

Jasmin Hundal, MDDionisia Quiroga, DO, PhD

Medical professionals discussing considerations and clinical trials for early-stage breast cancer treatment.

Breast Cancer

06/10/2026

Oncologists Consider Potential Roles of ADCs in Early-Stage Breast Cancer Treatment

Alexis Levee, MDHope Rugo, MD, FASCO

ASCO 2026 presentation on Giredestrant for ER+/HER2- metastatic breast cancer at Roswell Park Cancer Center.

Breast Cancer

06/10/2026

ASCO 2026: Evaluating Giredestrant in First-Line ER+/HER2- Metastatic Breast Cancer

Vaishali Deenadayalan, MD

Experts Alexis LeVee, MD, and Hope Rugo, MD, discuss optimizing ADC selection for metastatic triple-negative breast cancer treatment.

Breast Cancer

06/09/2026

The Current Paradigm for Selecting and Sequencing ADCs in Metastatic TNBC

Alexis Levee, MDHope Rugo, MD, FASCO

Experts discuss personalized adjuvant CDK4/6 inhibitor therapy for breast cancer in a professional conference setting.

Breast Cancer

06/08/2026

How to Select a CDK4/6 Inhibitor in Early or Metastatic Breast Cancer

Giuseppe Curigliano, MD, PhDArya Mariam Roy, MD

Two female doctors, Sarah Premji, MD, and Komal Jhaveri, MD, FACP, discussing biomarker testing for HR-positive metastatic breast cancer against a city skyline background.

Breast Cancer

06/07/2026

Biomarker Testing and Targeted Therapy Advancements in Metastatic Breast Cancer

Komal Jhaveri, MD, FACPSarah Premji, MD

Overview of six key breast cancer clinical trials presented at ASCO 2026, highlighting advancements in breast cancer treatment and research.

Breast Cancer

06/04/2026

Six Practice-Informing Breast Cancer Trials From ASCO 2026

Nerea Lopetegui-Lia, MD

Microscopic view of cancer cells with surrounding blood cells and immune response, illustrating recent oncological updates and advancements in cancer research.

Breast Cancer

08/26/2025

Updates in Breast Cancer From ASCO 2025

Zunairah Shah, MD

OncUpdates breast cancer clinical trials expert panel discussing key advancements in breast cancer treatment and innovative therapies. Featuring Dr. Erika Hamilton, Dr. Rohit Gosain, and Dr. Rahul Gosain.

Breast Cancer

07/22/2025

5 Key Breast Cancer Clinical Trials Shaping Treatment

Erika Hamilton, MD, FASCO

Innovative cancer research discussion at OncUpdates featuring leading oncologists sharing insights on recent advances in oncology treatments and therapies.

Breast Cancer

06/11/2025

Clinical Impact of DESTINY-Breast09 in HER2+ Breast Cancer Management

Arya Mariam Roy, MDHope Rugo, MD, FASCO

Advances in oncology, cancer research, and breakthrough treatments discussed at an oncology conference with medical professionals.

Breast Cancer

06/11/2025

Strategic Timing for Multidisciplinary Care in Breast Cancer

Jasmin Hundal, MDMatthew Kurian, MD

Two women engaged in a discussion on stage at the ASCO 2025 oncology conference, with a backdrop of plants and modern decor.

Breast Cancer

06/11/2025

Advancements in Oncology at ASCO 2025: Breast Cancer Highlights

Tanmayi Pai, MD

High-quality healthcare professional woman speaking at oncology conference, discussing cancer treatment updates, in a comfortable, modern setting with natural lighting and stylish decor.

Breast Cancer

06/10/2025

Key Takeaways From ASCO 2025 for Hormone-Receptor+ Metastatic Breast Cancer

Komal Jhaveri, MD, FACPMatthew Kurian, MD

Leading female medical expert speaking at a conference on oncology advances, holding a microphone, surrounded by large green plants, emphasizing innovative cancer research and treatment updates.

Breast Cancer

06/10/2025

Integrating Metastatic Triple-Negative Breast Cancer NCCN Guidelines Into Clinical Practice

Arya Mariam Roy, MDHope Rugo, MD, FASCO

Breast Cancer

06/10/2025

ASCENT-04 Trial: First-Line Sacituzumab Govitecan Plus Pembrolizumab Improves PFS in PD-L1+ TNBC

Arya Mariam Roy, MDHope Rugo, MD, FASCO